Resultados de la búsqueda 151-160 of 13307 for Suvorexant

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  5. Médicos y departamentos

    How dermatologists treat sun-damaged skin. American Academy of Dermatology. https://www.aad.org/public/everyday-care/sun-protection/sun-damage-skin/wrinkles-sun ...

  6. Hidradenitis supurativa

    Yun E. Managing hidradenitis suppurativa in Black skin. Everyday Health. https://www.everydayhealth.com/hidradenitis-suppurativa/managing-hidradenitis- ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a prospective, pilot, single arm study to evaluate the incidence of IIC in patients with solid malignancies receiving VSL#3 and ICIs.